- Home
- SOPH vs NKTR Comparison
SOPH vs NKTR Comparison
Compare SOPH & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPH
- NKTR
- Stock Information
- Founded
- SOPH 2011
- NKTR 1990
- Country
- SOPH Switzerland
- NKTR United States
- Employees
- SOPH N/A
- NKTR 61
- Industry
- SOPH Biotechnology: Biological Products (No Diagnostic Substances)
- NKTR Biotechnology: Pharmaceutical Preparations
- Sector
- SOPH Health Care
- NKTR Health Care
- Exchange
- SOPH Nasdaq
- NKTR Nasdaq
- Market Cap
- SOPH 231.8M
- NKTR 948.8M
- IPO Year
- SOPH 2021
- NKTR 1994
- Fundamental
- Price
- SOPH $3.23
- NKTR $51.07
- Analyst Decision
- SOPH
- NKTR Strong Buy
- Analyst Count
- SOPH 0
- NKTR 6
- Target Price
- SOPH N/A
- NKTR $81.67
- AVG Volume (30 Days)
- SOPH 38.8K
- NKTR 1.2M
- Earning Date
- SOPH 11-04-2025
- NKTR 11-06-2025
- Dividend Yield
- SOPH N/A
- NKTR N/A
- EPS Growth
- SOPH N/A
- NKTR N/A
- EPS
- SOPH N/A
- NKTR N/A
- Revenue
- SOPH $69,688,000.00
- NKTR $74,934,000.00
- Revenue This Year
- SOPH $16.60
- NKTR N/A
- Revenue Next Year
- SOPH $18.77
- NKTR N/A
- P/E Ratio
- SOPH N/A
- NKTR N/A
- Revenue Growth
- SOPH 7.32
- NKTR N/A
- 52 Week Low
- SOPH $2.58
- NKTR $6.48
- 52 Week High
- SOPH $4.92
- NKTR $52.75
- Technical
- Relative Strength Index (RSI)
- SOPH 46.63
- NKTR 85.95
- Support Level
- SOPH $3.10
- NKTR $42.12
- Resistance Level
- SOPH $3.49
- NKTR $50.53
- Average True Range (ATR)
- SOPH 0.16
- NKTR 3.47
- MACD
- SOPH -0.02
- NKTR 1.32
- Stochastic Oscillator
- SOPH 31.71
- NKTR 93.25
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
About NKTR Nektar Therapeutics
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.